This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk00: Good afternoon and welcome to the earnings conference call for the period ended December 31st, 2022 for MidCap Financial Investment Corporation. At this time, all participants have been placed in a listen-only mode. The call will be open for a question and answer session following the speakers' prepared remarks. If you would like to ask a question at that time, simply press star 1 on your telephone keypad. If you would like to withdraw your question, press star 2. I will now turn the call over to Elizabeth Besson, Investor Relations Manager for MidCap Financial Investment Corporation.
spk08: Thank you, Operator, and thank you, everyone, for joining us today. Speaking on today's call are Tanner Powell, Chief Executive Officer, Ted McNulty, President, and Greg Hunt, Chief Financial Officer. Howard Rudra, Executive Chairman, as well as additional members of the management team are on the call and available for the Q&A portion of today's call. I'd like to advise everyone that today's call and webcast are being recorded. Please note that they are the property of MidCap Financial Investment Corporation and that any unauthorized broadcast in any form is strictly prohibited. Information about the audio replay of this call is available in our press release. I'd also like to call your attention to the customary safe harbor disclosure in our press release regarding forward-looking information. Today's conference call and webcast may include forward-looking statements. You should refer to our most recent filings with the SEC for risks that apply to our business and that may adversely affect any forward-looking statements we make. We do not undertake to update our forward-looking statements or projections unless required by law. To obtain copies of our SEC filings, please visit our website at www.midcapfinancialic.com. I'd also like to remind everyone that we've posted a supplemental financial information package on our website, which contains information about the portfolio as well as the company's financial performance. Throughout today's call, we will refer to MidCap Financial Investment Corporation as either MFIC or the BDC, and we'll use MidCap Financial to refer to the lender headquartered in Bethesda, Maryland. At this time, I'd like to turn the call over to our Chief Executive Officer, Tanner Powell.
spk03: Thank you, Elizabeth. Good afternoon, everyone, and thank you for joining us today. I'd like to begin today's call by highlighting our results for the quarter, followed by a review of our investment strategy, including some performance data, which we believe shows why we're so confident in our strategies. I will then provide an update on the good progress we have made reducing our investment in Merck's and will conclude with the increase to our quarterly dividend. Following my remarks, Ted will review our investment activity and provide an update on portfolio credit quality. Lastly, Greg will review our financial results in detail and provide some additional comments on Merck's. We will then open the call to questions. Beginning with our financial results, after market closed today, we reported net investment income per share of $0.43, which benefited from the positive impact of higher base rates. As a reminder, there's generally some lag before we see the full impact of higher base rates due to the timing of loan resets. At the end of December, net asset value per share was $15.10, a decline of 2.3% quarter over quarter, mostly due to losses outside of our first lien corporate lending strategy. Regarding investment activity, new commitments continue to focus on first lien corporate loans sourced by MidCap Financial. We have also made significant progress reducing our exposures outside of our core strategy. Sales and repayments during the quarter included nearly all of our remaining oil and gas exposure, which is now less than $1 million at fair value. In addition, post-quarter end, we received a significant pay down from Merckx, reducing our position by roughly 24%. Pro forma for this pay down, Merckx represents approximately 8.3% of the portfolio at fair value. Shifting to a review of our investment strategy, as you may recall, in August, we made several key announcements which underscored Apollo Global Management's commitment to being at the forefront of the democratization of finance. These announcements included the establishment of a new and industry-leading fee structure for MFIC, an equity investment into the BDC by MidCap Financial, and a change in the company's name. These announcements reinforce MFIC's position as a pure-play, senior-secured, middle-market BDC, providing public shareholder access to institutional quality private credit at a best-in-class fee structure among listed BDCs. As you have heard us discuss on our previous calls, over the last several years, we have shifted the BDC's portfolio into first lien corporate loans, primarily sourced by MidCap Financial, one of the world's leading middle market lenders with a proven track record. MidCap Financial has one of the largest direct lending teams in the United States with close to 200 investment professionals. We believe the scale of MidCap Financial combined with other Apollo managed capital makes MFIC part of one of the largest market participants in middle market lending. For reference, in 2022, MidCap Financial closed approximately $16.4 billion in new commitments, including $4 billion in the December quarter. The BDC is fortunate to be in a unique position to have access to loans sourced by MidCap Financial, given the strategic relationship between MidCap Financial and Apollo Global. In mid-16, concurrent with the receipt of our co-investment order, MFIC shifted its strategic focus to leverage Apollo Global's relationship with MidCap Financial. I wanted to take a moment to provide some historical performance data, which we think shows how well this strategy has performed. As of June 2016, which is approximately the date upon which we began utilizing our co-investment order, our first lien corporate lending portfolio totaled approximately $300 million. At the end of December 2022, Our first lien corporate lending portfolio had grown to nearly $2 billion at fair value. Over that six and a half year period, we funded approximately $5.7 billion of new first lien corporate loans sourced by MidCap Financial. Total losses on those first lien corporate loans during that period have been approximately $7 million, or 12 basis points on a cumulative basis, or two basis points annually. We have We are highlighting this track record because we do not believe the market has fully appreciated how these assets have performed over an extended period of time, and because we believe it may help to inform how our first lien corporate lending portfolio should perform going forward. It is also worth noting that today's first lien corporate lending portfolio is not only well diversified by borrower and industry, but also across five distinct product groups, leverage lending, asset-based lending, lender finance, life science lending, and franchise finance. Moving to Merck's, consistent with our strategic focus on being a pure-play, senior-secured, middle-market BDC, we remain focused on accelerating the reduction of our investment in Merck's. We are pleased to report that we have made significant progress in this regard. At the end of December, MFIC's investment in Merck's had a fair value of $261 million, representing 10.9% of the total portfolio at fair value. Post-quarter-end, Merck's executed a significant transaction by selling its interest in a joint venture and repaid roughly $62 million to MFIC, which was applied to the revolver, reducing the size of MFIC's investment in Merck's to approximately $199 million, or 8.3 percent of the portfolio at fair value. We remain focused on continuing to reduce our investment in Merck's, and while we don't expect paydowns to occur evenly, we do expect to see additional paydowns in 2023 subject to market conditions. Greg will provide some additional color on the reduction in MERCs later during the call. Moving to our quarterly dividend, given the benefit we are seeing from higher base rates, the exit of lower yielding and non-earning legacy assets, and the expected benefit from our new fee structure, which became effective on January 1st, 2023, our board has increased MFIC's regular quarterly dividend by one cent from 37 cents to 38 cents, which equates to a 10% dividend yield based on December NAV. This dividend increase marks the third consecutive increase in our quarterly base dividend. At current base rates, we are well positioned to generate net investment income in excess of this new dividend level. The forward curve indicates that there will be additional rate increases, and rates will remain elevated for some time. As the operating environment continues to evolve, our board will continue to evaluate whether to retain additional earnings, increase the base dividend, or declare supplemental dividends. With that, I will turn the call over to Ted.
spk01: Thank you, Tanner. Beginning with a few thoughts on the current evolving macroeconomic environment, volatility in the leveraged finance and equity capital markets continued during the period as the Federal Reserve continued to raise interest rates to curb inflation amid ongoing concerns around slowing economic growth. In 2022, the Federal Reserve increased rates 425 basis points and has increased rates by an additional 25 basis points so far this year, with more rate increases expected, albeit at a slower pace. More recently, we have seen some signs of easing inflation, however, and Fed hawkishness is expected to keep markets volatile in the near term. As a result, primary new issuance in the leveraged loan and high-yield markets continues to be negatively impacted. We believe it will take time for the Federal Reserve's actions to be fully absorbed by the economy and therefore M&A transaction volumes will remain slower in the near term. We believe that the increased volatility in the public markets has created more attractive investment opportunities for direct lenders as more companies turn to the private debt markets. We're seeing wider spreads, lower leverage, and tighter documentation across our origination platform and continue to be selective, seeking to finance companies with defensible market share and resilient balance sheets. For example, credit spreads are at least 100 to 150 basis points higher than last year across our origination platform. With this as the market backdrop, we thought it would be worthwhile to remind everyone how we have constructed our corporate lending investment portfolio. We believe MFIC has one of the most senior secured portfolios among BDCs. Our corporate lending portfolio is focused on floating rate investments at the top of the capital structure, which we believe positions us well going into a weaker economic environment. In order to understand the stability and safety of our portfolio, we think it is important to focus on attachment points. At the end of December, the weighted average attachment point of our corporate lending portfolio was 0.2 times, which underscores that we are invested in the most senior part of the capital structure, or what we refer to as true first lien. By focusing on the top of the capital structure, we believe we will be able to mitigate some of the credit risks that could arise in a more challenging operating environment. Despite the more uncertain macroeconomic landscape, our borrowers have generally been able to navigate the current environment well, as evidenced by their fundamental performance. Our portfolio companies experienced positive year-over-year revenue growth in the most recent quarter and sound but slightly lower EBITDA growth. We believe our portfolio companies are generally entering 2023 with solid fundamentals and will be able to weather potentially more challenging conditions. To date, we have not seen any meaningful increase in either amendment activity or revolver drawdowns beyond the normal levels. That said, we acknowledge that some companies will have challenges in a slower economic environment, and we could see a pickup in amendment activity in the coming quarters. Importantly, MFIC benefits from MidCap Financial's dedicated portfolio management team of nearly 60 investment professionals, which helps identify and address issues early to maximize value. Moving to investment activity, we believe the middle market is generating attractive investment opportunities. As mentioned earlier, MidCap Financial was active during the December quarter, closing approximately $4 billion in new commitments. In the December quarter, MFIC's new corporate lending commitments totaled $73 million across nine companies for an average new commitment of $8.1 million. These new commitments were all first lien floating rate loans with a weighted average spread of 680 basis points, up 41 basis points compared to commitments made in the prior quarter. The higher spread on new commitments is another earnings tailwind we continue to see. The weighted average net leverage of new commitments made during the quarter was 4.8 times, which is 0.7 times below the 5.5 times average of our portfolio. Excluding revolvers, gross fundings for the quarter totaled $105 million and sales and repayments totaled $141 million. Net repayments for revolvers totaled $11 million. In aggregate, net repayments for the quarter totaled $48 million. Especially notable, sales and repayments included roughly $21 million from our remaining oil and gas exposure, which is now less than $1 million at fair value. In 2022, we sold all of our ships and oil and gas assets as we continue to accelerate the execution of our true first lean strategy. Turning to the overall portfolio, our investment portfolio had a fair value of $2.4 billion at the end of December across 135 companies in 26 different industries. Corporate lending and other represented 89% of the total portfolio, and Merck's represented 11% of the portfolio at fair value. As Tanner mentioned, post-quarter end, Merckx has been reduced to approximately 8% of the total portfolio at fair value. At the end of December, 94% of our corporate lending portfolio was first lien with a weighted average spread of 610 basis points. Our portfolio company credit metrics remain relatively stable during the quarter. At the end of December, the weighted average net leverage of the corporate lending portfolio was 5.49 times, down from 5.52 times last quarter. The weighted average interest coverage ratio was 2.5 times, down from 2.7 times last quarter. These weighted average interest coverage ratios are based on company data for the last 12 months through September. The weighted average interest coverage ratio was 1.9 times, based on an annualized interest expense for the September quarter and using the last 12 months of EBITDA. Given the significant and rapid increase in base rates, we're focused on current and future interest coverage and fixed charge coverage ratios across the portfolio as a component of an active risk monitoring process. No investments were placed on non-accrual status during the quarter. At the end of December, investments on non-accrual status totaled $10 million or 0.4% of the total portfolio at fair value. With that, I will now turn the call over to Greg to discuss our financial results in detail.
spk06: Thank you, Ted, and good afternoon, everyone. Before discussing our results, I wanted to remind everyone that MFIC has changed its fiscal year end from March 31st to December 31st. The change in fiscal year was done to better align MFIC's reporting calendar with other Apollo global entities. The transition report on Form 10-K, which was filed today, includes a nine-month period from April 1st, 2022 through December 31st, 2022. MFIC's next fiscal year will cover the period from January 1st, 2023 to December 31st, 2023. You can see the year-over-year results in the 10-K that we filed today. Shifting to our results, net investment income per share for the December quarter was $0.43 compared to $0.35 for the September quarter and $0.35 in the year-ago quarter. Net investment income for the December quarter continued to benefit from higher base rates on our floating rate assets, solid fee and prepayment income, as well as a lower incentive fee compared to the comparable periods. Prepayment income was $2.8 million, down slightly from last quarter, and fee income was approximately $700,000 compared to $1.5 million last quarter. Dividend income was essentially flat quarter over quarter. The yielded cost in our corporate lending portfolio was 10.3% on average for the quarter, an increase of 140 basis points from last quarter, driven by the increase in base rates. This yield figure is an average of the beginning and the end of the quarter. At the end of December, the yield of the corporate lending portfolio was approximately 11%, compared to 9.6% at the end of September. NAV per share at the end of December was $15.10, a 2.3% decrease quarter over quarter, primarily driven by losses outside of our first lien lending book. In that regard, and as previously indicated, Our corporate lending portfolio of $2.1 billion is made up of 94% first liens. Losses, less than 10% of our losses, or $2.3 million, were attributed to our first lien corporate lending book and was primarily due to mark-to-market adjustments from spread widening as opposed to fundamental credit losses. Additional details on the net losses are shown on page 16 of in the earnings supplement. MFIC's incentive fee on income includes a total return hurdle with a rolling 12-month, 12-quarter look back. Given the net loss on the portfolio, incentive fees in the December quarter were significantly reduced. As a reminder, beginning on January 1st, 2023, MFIC's base management fee was permanently reduced to one and three-quarters on equity. Among listed BDCs, MFIC's management fee is now the lowest and is the only listed BDC to charge management fees on equity, which we believe provides a greater alignment and focus on net asset value. The incentive fee rate on income was also permanently reduced from 20% to 17.5%, and we retained the total return feature. Moving on from our balance sheet perspective, our net leverage stood at 1.4 times at the end of December within our target range. We intend to amend and extend our revolving credit facility in the next few months. Although no stock was purchased during the quarter, we believe MFIC's trading discount to NAV implies a loss rate significantly higher than our first lien corporate lending portfolio has experienced over the last six and a half years. Moving to MERX, as Tanner In January, Merck sold its 50% interest in a joint venture, reducing Merck's fleet from 57 aircraft to 43 today. Proceeds from this sale were applied to the MFIC note, reducing our investment in Merck's to approximately 8.3% of the portfolio at fair value. This sale, in combination with other steps taken in connection with the reduction of our exposure to Merck's, resulted in a nominal write down on our investment during the quarter. Turning to our outlook, we believe we are well positioned to grow earnings in the coming quarters due to the rising interest rate environment. For perspective, based on quarter end rates, we estimate that a 50 basis point and 100 basis point increase in base rates would result in incremental annual earnings of approximately 6 and 13 cents respectively. We have provided additional information on the sensitivity in our 10-K. As we enter 2023, we feel very constructive about the outlook for MFIC, given the diversity of our corporate lending portfolio, which we believe is designed to weather a more challenging economic environment. This concludes our prepared remarks, and operator, please open up the call to questions.
spk00: Thank you, sir. At this time, if you would like to ask a question, please press the star and 1 keys on your touchtone phone. If at any time you find your question has been answered, you may remove yourself from the queue by pressing star 2. Once again, that is star 1 to ask a question. And our first question will come from Mark Hughes with Truist. Your line is open.
spk07: Yeah, thank you. Good afternoon. Good afternoon. For Merck, I think you talked about the opportunity for more pay down in 2023. Are transactions required in order to generate that, or can they pay down just from operating cash flow?
spk03: Yeah, so thanks, Mark. So the answer there is it is not – necessary for big wholesale transactions. We've got, as Greg mentioned, 43 planes in the portfolio today. To state the obvious, these are not QSIP securities, so they cannot be traded on the wire. It's a long process in order to execute on these sales. And there are tax considerations as well. We do have a yield on the portfolio today to see substantial moves in the reduction of our exposure there. You would expect to need sales of assets either individually or in larger groups.
spk07: Within the portfolio, the high-tech industry is about 17%, I think. Any impact there? There's been some volatility in the tech on the job front. Are you seeing any of that within your portfolio?
spk03: No. In high-tech, you know, we – This was a delineation that was made back in 2006 when the fund was founded, and it catches a lot of things, including software, which is something that the broader market has done quite a bit. When we think about the exposure there, the good news from a software standpoint is oftentimes the software itself is the different companies are targeting different underlying markets with different fundamentals, and oftentimes we're creating those deals typically at an even lower LTV than our average LTV across our leveraged lending portfolio, which is roughly 50%. So there's significant cushion in any event, notwithstanding, as you rightly pointed out, there are some broader challenges in the tech space.
spk07: Appreciate it. Thank you.
spk00: Thank you. Our next question will come from Robert Dodd with Raymond James. Your line is open.
spk02: Hi, guys. Just on one of the questions, I think in your prepared remarks, you said, you know, spreads have widened significantly, 100 to 150 basis points. And we've heard others say the same thing. But to that point, when I look at your new commitments, what do you think? 680 this quarter, 639 last quarter, but it was also 639 a year ago. So that's about 40 basis points in widening. And on the new commitments, the leverage is about the same. So could you give us, have you taken the opportunity, I assume that 100 to 150 is kind of like for like, have, you know, over the course of the year, have you taken the opportunity to go even more cautious on the assets? And maybe that's, folding back the visibility of the spread expansion in new commitments? So any colleagues on that?
spk03: Yeah. Thanks, Robert. I think it's absolutely that, and it's a little bit also that when we quote those numbers, we're looking kind of across our businesses, kind of across our middle market lending platform and what we're doing at MidCap. And I think this is a good point to emphasize. This is one of the dynamics that drove our decision to reduce our cost structure and give us the ability to participate in an even greater percentage of what MidCap is sourcing. And so while we were always You know, trying to be in the 600s where we could. In the most recent quarter, you do see, you know, us deploying roughly $75 million at the 680, which we would think is reflective of the market. And to your point, reflects both, one, that we're trying to stay a little bit more conservative, as well as also, you know, in anticipation of the broader market, sorry, the fee change. that we can participate in a greater percentage of the deals, and effectively our cost of capital has come down.
spk02: Got it. Got it. I appreciate that. I mean, one more on kind of the energy exits. I mean, was that – I don't want to word this in a way. I mean, I presume that's something that's been worked on a while rather than just a decision to – just get out all at once this quarter. So, I mean, obviously there were some realized losses, but we kind of knew that. But could you give us any comment on, you know, getting rid of them all in one quarter, which is quite active? What really drove that? Or did it just all happen to come together?
spk01: Yeah, sure, Robert. Happy to address that. So several years ago, we began the process of migrating towards the broader strategy. And starting in 2020 and then in 2021, we took the opportunity to work with the management teams and restructure the business. and get those businesses ready to go to market. And then did so in 2022, you know, in some cases, hiring advisors, running processes, you know, and this is across oil and gas as well as the shipping assets that we sold last year. And, you know, it just so turns out that for both of the assets, they ended up closing, you know, in the quarter and, the two oil and gas assets. So they have been worked on for, you know, operationally, financially for a couple of years, and then in terms of actual M&A process over the course of the year.
spk00: Got it.
spk02: Thank you.
spk01: Yep.
spk00: Thank you. And as a reminder, that is star one to ask a question. Our next question will come from Ryan Lynch with KBW. Your line is open.
spk04: Hey, good afternoon. I had a – my first question was just on kind of the nature that you guys described the write-downs in the NAVDAS court. I believe you said they were mostly due to spread widening, but wasn't the largest markdown really coming from your corporate lending book, and that was really just driven by the debt-to-equity restructuring of K&N, which to us would seem like kind of a credit markdown? So I guess – I'm just a little bit confused on misunderstanding of why the markdowns this quarter were kind of described as mostly spread widening versus credit.
spk01: Yeah, no, I think the – and thanks for the comment, and I'm happy to clarify that. You know, you're right. There was, you know, one part of the write-down component that was second lien. That was the K&N investment that went through restructuring, which was completed, you know, post-quarter end. And then I think in the prepared comments, the comment was within the first lien credit book. the write-down within the first lien credit was the mark-to-market. So it was really kind of two different components there.
spk03: Yeah, the prepared remarks, Ryan, were emphasizing that it was outside of the first lien strategy that we saw the big decline, and you're exactly right. That was largely due to the K&N write-down.
spk01: Okay. Yeah, and within the corporate strategy, it was a mark-to-market.
spk04: Gotcha. Gotcha. And then you guys gave some statistics on weighted average interest coverage, 2.5 times on trailing 12 months, 1.9 times in September annualized. Have you guys done any sort of analysis that looks at what that interest coverage is going to look like in calendar 2023 when kind of LIBOR or SOFR kind of peak out and then Obviously, the weighted average interest coverage is kind of the mostly quoted statistic. But, you know, from a credit standpoint, you know, I don't think most investors are sort of worried about the average borrower defaulting. I think it's more likely in the risks or more in the tail ends of potential borrowers having issues. So have you guys done any sort of analysis on that? at what interest coverage would look like on a forward basis and what percentage of your portfolio would fall below that one times interest coverage level?
spk03: Yeah, sure. So I appreciate these numbers are a little bit backward looking. And so what we've done, or of all the analysis, to distill it down to the conclusion, when you take the current LIBOR, kind of thinking the 477 or the LIBOR as of 12, the LIBOR slash SOFR at the end of the year, we just have a handful, kind of less than five names that fall below one times coverage. And then we stress that another 100 basis points, which is slightly above what the market is pricing in, in terms of increases to LIBOR slash SOFR slash interest rates, that number only increases by three or four names. And so still in that context, even with, you know, call it 575 to 6% SOFR, we're seeing, you know, fewer than 10 names, you know, below one to one. And that, of course, is before the benefit of the year to address and offset some of that increase in the underlying companies.
spk04: Okay. That's really helpful. And then just one final one. On the reduction in MERCs, those interests being sold, is that what we should sort of expect going forward is more sort of these chunkier dispositions that kind of come over time? Or do you guys expect sort of a gradual repayment schedule of those to the extent that you guys can predict anything like that, which may not be possible?
spk05: Uh, yeah, I mean, I think we would expect it to be a little bit of a step function, which would, which would be lumpy, but probably not as lumpy as the one this quarter. So, you know, uh, there, there are like sets of assets that sort of obviously go together, you know, same less or for example, uh, let's see, for example, that we would expect to exit. So, yeah, so, I mean, I think it will be more, you know, plane by plane as opposed to sort of like complete entities, but it won't necessarily be just like, you know, one by one by one. So, I know that's like an imperfect answer. So, but that's our expectation.
spk04: No, that makes sense. Okay. imperfect sort of process trying to sell these things off, so I definitely understand the unpredictability of it. I appreciate the time this afternoon. Thank you.
spk00: Once again, that is star one to ask a question. And our next question will come from Melissa Waddell with J.P. Morgan. Your line is open. Good afternoon.
spk09: Thanks for taking my questions today. I was hoping you could touch on portfolio leverage and how you're feeling about current levels. I would assume that with where you're at currently at about just about 1.4 on a net basis, that you're still in sort of a bit of a capital recycling mode as repayments come in and exits occur. Is that a fair assumption or are you thinking about things differently?
spk03: I think that's a fair assumption. You know, that is the, you know, 141 where we came out this quarter is at the bottom of our range. We did provide guidance last quarter that we would expect to operate in and around that range. And to your point, redeploying what comes back to us. I would note, and hopefully it's obvious from some of the other comments and questions, is we do believe that, you know, further economic volatility notwithstanding, this will be a good vintage for credit lenders on account of good spread, improving documentation, and lower all-in leverage. And so, you know, we do want to participate in this market and make sure we are properly indexed to what we believe is a good market for private credit and make sure MFIC is the beneficiary of that.
spk09: Okay, I appreciate that. And I think, you know, as a follow up on some of the outstanding commitments, and I'm looking at slide 18 in your deck, specifically, as you think about sort of the commitments available to be drawn down on, I think I'm looking about 193, kind of rounding 193 million, as you think about the potential for a more challenging operating environment. Are you expecting to see that number start, you know, being drawn upon by existing portfolio companies? And if that's the case, I assume that the terms have already been set, so they're not sort of dictated by the current environment, but by the terms that were agreed upon, you know, when that commitment was made. Could you just kind of elaborate on that process a little and how you're thinking about it. Thanks so much.
spk03: Yeah, sure. Melissa, very good question. Um, and so, you know, the first point is we, we have not seen a tick up in revolver utilization across MFIC or our broader business. And I think, you know, on, on this, on this account, you know, good news, bad news is the bad news is we went through, we went through COVID, but the good news is, and having gone through COVID, and experienced those instances wherein there was the preemptive drawing down of the revolvers, we had the opportunity, both in new loans as well as also in existing loans, to put in the type of terms to protect on the margin against, such as anti-cash hoarding and eliminating netting in terms of covenant compliance. And so while, you know, if you know, stresses are more acute than we expect or are continuing at the level. Obviously, cash flows may become challenged and you would expect a higher utilization, but we haven't seen, and at a minimum, on account of what we've been able to do from a documentation standpoint, think that that risk of excessive drawdowns within our revolvers to be much less risk than what we've seen historically.
spk01: And then on the term loans, those have defined use of proceeds as well. So they're primarily in place to support sponsors going to make acquisitions to grow their portfolio companies. And so the delayed draw term loans, which is I think what you were pointing at on the slide, you know, those can't be drawn down just for liquidity purposes.
spk00: Thank you. Thank you. And at this time, we have no further questions in the queue, so I would like to turn it back over to management for any additional or closing remarks.
spk03: Thank you, operator. Thank you, everyone, for listening to today's call. On behalf of the entire team, we thank you for your time today. Please feel free to reach out to us if you have any other questions. Have a good evening.
spk00: Thank you, ladies and gentlemen. This does conclude today's conference call, and we appreciate your participation. You may disconnect at any time.
Disclaimer